China's COVID-19 scare sparks run on flu medicines, test kits as far away as Australia | Inquirer News

China’s COVID-19 scare sparks run on flu medicines, test kits as far away as Australia

/ 04:52 PM December 15, 2022

China's COVID-19 scare sparks run on flu medicines

 People stand in a queue to purchase medicines at a pharmacy in Beijing, China December 14, 2022, in this screen grab taken from a Reuters TV video. REUTERS TV via REUTERS/File Photo

SYDNEY/BEIJING — The rising alarm over COVID-19 spreading in China was felt in pharmacies in Hong Kong, Macau, and in some neighborhoods in Australia, as people hunted for fever medicines and virus test kits to send to family and friends on the mainland.

China’s sudden easing of strict COVID rules last week triggered a surge in demand for these items on the mainland, with queues forming outside pharmacies and online platforms quickly selling out.

Article continues after this advertisement

Several shops have since imposed limits on how much customers can buy, and drugmakers are ramping up production.

FEATURED STORIES

“Chinese people like to hoard things. How could there be anything left? They like to hoard medicines before they even get sick,” said a doctor in Shanghai.

Chang Linyun, a 42-year-old mother in Beijing, said she tried to ask friends in Australia to buy fever medicine for her young son, as the drugstores were sold out, and traders who use social media and mobile apps to source and provide goods to customers, known as “daigou”, were charging too much.

Article continues after this advertisement

“I’d like to buy two bottles of Panadol and two bottles of Nurofen… (But) my friend told me that drug stores near her home in Melbourne have all sold out of fever medicine, because too many Chinese daigou are buying,” Chang said.

Article continues after this advertisement

In Box Hill, a suburb of Melbourne and home to one of Australia’s largest Chinese communities, a pharmacist said several drugstores had run out of Panadol.

Article continues after this advertisement

In Hong Kong, two sales staff in a pharmacy shop said there were very low stocks of Panadol across its network in the city, even as its Health Secretary Lo Chung-mau said on Sunday that the government will ensure the supply of paracetamol-based drugs to calm fears of a shortage.

“I have friends in Beijing who asked me to send over some flu medicines and rapid tests. They just couldn’t get any in Beijing, they placed orders online, but nothing gets sent,” said a 30-year-old woman in Hong Kong surnamed Lo who was buying flu and anti-fever medicines and COVID tests to send to her friends.

Article continues after this advertisement

In Macau, health authorities have imposed purchase limits for antiviral drugs used to treat COVID-19 symptoms.

Xiangxue Pharmaceutical, which produces an antiviral solution, said on Monday it was “going all out” to increase output in response to a question on the shortages in pharmacies.

And the government-backed Sinopharm Group has tripled daily production capacity of key drugs, state run CCTV reported, due to a sharp increase in demand for medicines to treat fever and cough symptoms.

RELATED STORIES

China’s healthcare system put to the test as COVID-19 curbs fade

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

‘Please protect yourself’: China wrestles with COVID-19 surge

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Australia, China, COVID-19, Health

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.